U.S. markets closed

C21 Investments Inc. (CXXIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3009+0.0189 (+6.72%)
At close: 03:36PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2820
BidN/A x N/A
AskN/A x N/A
Day's Range0.2809 - 0.3040
52 Week Range0.2300 - 0.8500
Avg. Volume24,085
Market Cap36.127M
Beta (5Y Monthly)2.61
PE Ratio (TTM)10.03
EPS (TTM)0.0300
Earnings DateSep 26, 2022 - Sep 30, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CXXIF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: Curaleaf Holdings, Inc.Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 22 states, including the assets from the Cura Select and Grassroots acquisitions. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
  • Newsfile

    C21 Investments Provides MCTO Status Update

    Vancouver, British Columbia--(Newsfile Corp. - August 4, 2022) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").As previously announced on May 30, 2022 (the "Announcement"), the Company applied for a management cease trade order ("MCTO") from the British C

  • CNW Group

    C21 Investments Announces Unaudited Year End Results and Provides MCTO Status Update

    C21 Investments Inc. (CNSX: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced unaudited results for its fiscal year ended January 31, 2022. The Company's unaudited financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles ("GAAP"). Note that all current and prior period financial results are presented with the Company's Oregon activities having been classified as discontinued, with the exception of Ne

  • Newsfile

    C21 Investments Announces Delay in Filing Annual Financial Results and Application for Management Cease Trade Order

    Vancouver, British Columbia--(Newsfile Corp. - May 30, 2022) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced a delay in filing its audited annual financial statements and management discussion & analysis for the financial year ended January 31, 2022, and the CEO and CFO certificates, all as required by National Instrument 51-102 - Continuous Disclosure Obligations and National Instrument 52-109 - Certification